The associations between metabolic variables and NT-proBNP are blunted at pathological ranges: the Multi-Ethnic Study of Atherosclerosis.

[1]  J. Spence.  Faculty Opinions recommendation of Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. , 2013 .

[2]  J. Coresh,et al.  NH2-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes , 2013, Diabetes.

[3]  J. Jeppesen,et al.  Relative Atrial Natriuretic Peptide Deficiency and Inadequate Renin and Angiotensin II Suppression in Obese Hypertensive Men , 2013, Hypertension.

[4]  J. Polak,et al.  Carotid artery plaque and progression of coronary artery calcium: the multi-ethnic study of atherosclerosis. , 2013, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[5]  R. Kronmal,et al.  The Value of Carotid Artery Plaque and Intima‐Media Thickness for Incident Cardiovascular Disease: The Multi‐Ethnic Study of Atherosclerosis , 2013, Journal of the American Heart Association.

[6]  V. Rac,et al.  Novel biomarkers in diagnosing cardiac ischemia in the emergency department: a systematic review. , 2012, Resuscitation.

[7]  P. Armstrong,et al.  Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial , 2012, Journal of Thrombosis and Thrombolysis.

[8]  Thomas J. Wang,et al.  Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study. , 2012, The Journal of clinical endocrinology and metabolism.

[9]  Jian-gui He,et al.  Acute myocardial ischemia directly modulates the expression of brain natriuretic peptide at the transcriptional and translational levels via inflammatory cytokines. , 2011, European journal of pharmacology.

[10]  D. Levy,et al.  Reference limits for N-terminal-pro-B-type natriuretic peptide in healthy individuals (from the Framingham Heart Study). , 2011, The American journal of cardiology.

[11]  Hao Wang,et al.  New insights into the mechanism of low high-density lipoprotein cholesterol in obesity , 2011, Lipids in Health and Disease.

[12]  Inês Barroso,et al.  Mendelian Randomization Study of B-Type Natriuretic Peptide and Type 2 Diabetes: Evidence of Causal Association from Population Studies , 2011, PLoS medicine.

[13]  N. Girerd,et al.  N-Terminal Pro-Brain Natriuretic Peptide: A Powerful Predictor of Mortality in Hypertension , 2011, Hypertension.

[14]  D. Conen,et al.  Determinants of absolute and relative exercise-induced changes in B-type natriuretic peptides. , 2011, International journal of cardiology.

[15]  L. Nielsen,et al.  Decreased expression of natriuretic peptides associated with lipid accumulation in cardiac ventricle of obese mice. , 2010, Endocrinology.

[16]  J. Danesh,et al.  B-Type Natriuretic Peptides and Cardiovascular Risk: Systematic Review and Meta-Analysis of 40 Prospective Studies , 2009, Circulation.

[17]  K. Nakao,et al.  Natriuretic Peptides/cGMP/cGMP-Dependent Protein Kinase Cascades Promote Muscle Mitochondrial Biogenesis and Prevent Obesity , 2009, Diabetes.

[18]  M. Pencina,et al.  Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. , 2009, JAMA.

[19]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[20]  A. Jaffe,et al.  Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage. , 2008, Clinical chemistry.

[21]  V. Appanna,et al.  Aluminum-Induced Mitochondrial Dysfunction Leads to Lipid Accumulation in Human Hepatocytes: A Link to Obesity , 2007, Cellular Physiology and Biochemistry.

[22]  W. März,et al.  N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study. , 2007, Clinical chemistry.

[23]  Xin Xu,et al.  Renal hyporesponsiveness to atrial natriuretic peptide in congestive heart failure results from reduced atrial natriuretic peptide receptor concentrations. , 2007, American journal of physiology. Renal physiology.

[24]  D. Bluemke,et al.  Subclinical atherosclerosis and incipient regional myocardial dysfunction in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2006, Journal of the American College of Cardiology.

[25]  S. Lai,et al.  Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity. , 2006, AJR. American journal of roentgenology.

[26]  A. Khera,et al.  Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study). , 2005, The American journal of cardiology.

[27]  T. Jørgensen,et al.  N-Terminal Pro Brain Natriuretic Peptide Is Inversely Related to Metabolic Cardiovascular Risk Factors and the Metabolic Syndrome , 2005, Hypertension.

[28]  P. W. Leeuw,et al.  Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology , 2005, Fundamental & clinical pharmacology.

[29]  J. Rehfeld,et al.  Acute myocardial hypoxia increases BNP gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[31]  Alan S Maisel,et al.  Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. , 2002, The New England journal of medicine.

[32]  A. Leon,et al.  Response of blood lipids to exercise training alone or combined with dietary intervention. , 2001, Medicine and science in sports and exercise.

[33]  M. Berlan,et al.  Natriuretic peptides: a new lipolytic pathway in human adipocytes , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  N. Arakawa,et al.  Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure. , 1998, American heart journal.

[35]  R. Sarzani,et al.  Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients , 1997, Journal of Hypertension.

[36]  S. Cinti,et al.  Fasting inhibits natriuretic peptides clearance receptor expression in rat adipose tissue , 1995, Journal of hypertension.

[37]  S. Young.  Recent Progress in Understanding Apolipoprotein B , 1990, Circulation.

[38]  R. Detrano,et al.  Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.

[39]  P. Braquet,et al.  Down-regulation of atrial natriuretic factor receptors and correlation with cGMP stimulation in rat cultured vascular smooth muscle cells. , 1987, Biochemical and biophysical research communications.

[40]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[41]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[42]  A. Keys,et al.  Effect of dietary cholesterol on man's serum lipids. , 1965, The Journal of nutrition.

[43]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2015 .

[44]  C. Passino,et al.  Circulating forms of the b-type natriuretic peptide prohormone: pathophysiologic and clinical considerations. , 2012, Advances in clinical chemistry.

[45]  D. Jacobs,et al.  Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR >60 mL/min/1.73 m(2): the Multi-Ethnic Study of Atherosclerosis (MESA). , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[46]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[47]  D. Gardner,et al.  Endothelin-dependent and -independent components of strain-activated brain natriuretic peptide gene transcription require extracellular signal regulated kinase and p38 mitogen-activated protein kinase. , 2000, Hypertension.

[48]  J. Karl,et al.  Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. , 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.